EGFR and lung carcinoma: Furthermore, DNA damage and persistence of genetic alterations may negatively affect the survival rates of young smokers among EGFR-mutant lung cancer patients, which may consequently have substantial implications on the need for preventing adolescent smoking, particularly in this era of targeted therapy.